BRIEF-FDA Approves First Generic Of Flovent HFA For Treatment Of Asthma

GlaxoSmithKline plc Sponsored ADR -1.18%

GlaxoSmithKline plc Sponsored ADR

GSK

57.13

-1.18%

- FDA:

  • FDA: APPROVES FIRST GENERIC OF FLOVENT HFA FOR TREATMENT OF ASTHMA